Pictet Asset Management (Switzerland)’s Ionis Pharmaceuticals IONS Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$127M	Buy	3,095,670 +1,982,628	+178%	+$76.2M	0.15%	174
2023 Q1	$39.8M	Buy	1,113,042 +739,456	+198%	+$27.8M	0.05%	332
2022 Q4	$14.1M	Buy	373,586 +96,609	+35%	+$4.06M	0.02%	522
2022 Q3	$12.3M	Buy	276,977 +38,638	+16%	+$1.63M	0.02%	532
2022 Q2	$8.82M	Buy	238,339 +32,198	+16%	+$1.21M	0.01%	633
2022 Q1	$7.63M	Buy	206,141 +23,054	+13%	+$755K	0.01%	712
2021 Q4	$5.57M	Buy	183,087 +47,391	+35%	+$1.49M	0.01%	810
2021 Q3	$4.55M	Buy	+135,696	New	+$5.11M	0.01%	857

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s IONS Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Ionis Pharmaceuticals (IONS) stake by 178% in Q2 2023, buying an estimated $76.2M and bringing the position to 3,095,670 shares worth $127M. The position accounts for 0.15% of the portfolio, ranked #174.

Pictet Asset Management (Switzerland) first reported a position in IONS in Q3 2021 and has held it in 8 quarters since. 305 funds tracked by Wall St. Rank hold IONS as of Q2 2023.

Pictet Asset Management (Switzerland) held 3,095,670 shares of Ionis Pharmaceuticals worth $127M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 1,982,628 Ionis Pharmaceuticals shares in Q2 2023, an estimated $76.2M.
Ionis Pharmaceuticals made up 0.15% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #174 holding.
Pictet Asset Management (Switzerland) first reported a position in Ionis Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
305 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.